Hamilton C, Dalrymple H, Reid J
J Cardiovasc Pharmacol. 1982;4 Suppl 1:S125-8. doi: 10.1097/00005344-198200041-00025.
Phenoxybenzamine is an irreversible, selective alpha 1-adrenoceptor antagonist that results in long-lasting attenuation of the effects of alpha-adrenoceptor agonists in vivo and in vitro. We have studied in rabbits the time course of recovery of in vivo pressor responses to phenylephrine and in vitro contractile responses of spiral strips of renal artery to phenylephrine and noradrenaline. The maximum number of binding sites and the dissociation constant has been determined using 3H-prazosin in spleen and heart membranes prepared at intervals up to 8 days after phenoxybenzamine 5 mg/kg intravenously. In vitro contractile responses recovered over 2-3 days and by 4 days the EC50 was lower than control. In vivo pressor responses recovered over 5-8 days to control levels. The number of binding sites was only 50% of control at 8 days. It is proposed that under the conditions studied the recovery of binding sites may provide an index of turnover of alpha-adrenoceptors. The results also suggest that postreceptor mechanisms contribute to the increased responses observed in vitro.
酚苄明是一种不可逆的、选择性α1肾上腺素能受体拮抗剂,可在体内和体外长期减弱α肾上腺素能受体激动剂的作用。我们在兔子身上研究了对去氧肾上腺素的体内升压反应以及肾动脉螺旋条对去氧肾上腺素和去甲肾上腺素的体外收缩反应的恢复时间进程。在静脉注射5mg/kg酚苄明后长达8天的不同时间点制备的脾脏和心脏膜中,使用3H-哌唑嗪测定了结合位点的最大数量和解离常数。体外收缩反应在2 - 3天内恢复,到第4天时,半数有效浓度(EC50)低于对照。体内升压反应在5 - 8天内恢复到对照水平。在第8天时,结合位点的数量仅为对照的50%。有人提出,在所研究的条件下,结合位点的恢复可能提供α肾上腺素能受体更新的指标。结果还表明,受体后机制促成了体外观察到的反应增强。